Source: Korea Biomedical Review

ILDong: Ildong nears getting nod for Covid-19 pill in Korea after winning Japan's approval

Ildong Pharmaceutical said that Japan's Ministry of Health, Labour and Welfare has granted emergency use approval (EUA) for Shionogi & Co's Xocova, an oral Covid-19 treatment Ildong has been co-developing.Shionogi applied for conditional approval for Xocova to Japan's Ministry of Health, Labor and W

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Lee Jung-chi's photo - CEO of ILDong

CEO

Lee Jung-chi

CEO Approval Rating

66/100

Read more